The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...

Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...